JDBIO Participates in the Asia Pacific Anti-Aging Conference 2025 (APAAC 2025) in Daegu
JDBIO participated in the 8th Asia Pacific Anti-Aging Conference (APAAC 2025) held from September 27 to 28, 2025, at EXCO in Daegu, further solidifying its presence in the global medical beauty market.
Now in its 8th year, APAAC is an international conference hosted annually in Daegu, known as “Medi-City Daegu.” The event serves as a major anti-aging and beauty conference in the Asia-Pacific region, aiming to support global market expansion for outstanding regional products and foster international cooperation initiatives through a network of medical professionals and experts from 13 countries.
At this year’s exhibition, JDBIO showcased its premium medical beauty portfolio—including RICHESSE™, DEMEI™, One Tox®, Exo'One™, OneFill™, and TEOFIL™—introducing specialized solutions focused on skin regeneration, elasticity improvement, and anti-aging. Continuous consultations with domestic and international buyers and medical experts indicated strong interest in the company’s products and technological capabilities.
As an official sponsor, JDBIO also hosted a luncheon seminar, where the company presented its vision for rapid global growth as a leading total K-Beauty solution provider.
JDBIO offers a wide range of premium aesthetic products—including its own brands RICHESSE™, DEMEI™, One Tox®, Exo'One™, OneFill™, and TEOFIL™—as well as various renowned Korean fillers, botulinum toxin products, skin boosters, lipolysis injections, and professional skincare solutions. The company continues to expand its global footprint, exporting to more than 30 countries across Asia, Europe, and the Americas.
Moving forward, JDBIO will continue to promote the excellence of K-Beauty to buyers and experts worldwide and strengthen its position as a global leader in the medical beauty and aesthetics industry.